Clinical Trials Browser

Phase 1/2 × INDUSTRY × volociximab × Clear all

NCT00635193 2013-01-18

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Phase 1/2 Completed

Ovarian Neoplasms